共 17 条
Dihydromyricetin induces cell apoptosis via a p53-related pathway in AGS human gastric cancer cells
被引:32
作者:
Ji, F. J.
[1
]
Tian, X. F.
[1
]
Liu, X. W.
[2
]
Fu, L. B.
[3
]
Wu, Y. Y.
[1
]
Fang, X. D.
[1
]
Jin, H. Y.
[1
]
机构:
[1] Jilin Univ, China Japan Friendship Hosp, Dept Gen Surg, Changchun 130023, Peoples R China
[2] Jilin Cent Hosp, Dept Gen Surg, Changchun, Jilin, Peoples R China
[3] Peoples Hosp Panan Cty, Dept Gen Surg, Hangzhou, Zhejiang, Peoples R China
关键词:
Dihydromyricetin;
Gastric cancer;
Cytotoxicity;
Apoptosis;
p53;
DEATH;
LIFE;
MITOCHONDRIA;
PROTEINS;
D O I:
10.4238/2015.December.1.7
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
The aim of the present study was to determine the anti-proliferative and pro-apoptotic effects of dihydromyricetin (DHM) on the AGS human gastric cancer cells and their underlying mechanisms. The effects of DHM on AGS cells were evaluated by using 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), lactate dehydrogenase, and Annexin V/propidium iodide (PI) double-staining assays. The underlying mechanisms were determined by using quantitative real-time polymerase chain reaction. The results demonstrated that DHM significantly (P < 0.05) inhibited AGS cell proliferation and induced cell cytotoxicity in a dose-and time-dependent manner. Additionally, Annexin V/PI double-staining assay showed that DHM promoted cell apoptosis in both, early and late stages. Furthermore, DHM also regulated the expression of apoptotic genes such as p53 and B-cell lymphoma-2 (bcl-2) in a dose- and time-dependent manner. In conclusion, this is the first report demonstrating the anticancer and pro-apoptosis effects of DHM on AGS human gastric cancer cells. The results strongly suggest that DHM may be a potential therapeutic candidate for the treatment of gastric cancer.
引用
收藏
页码:15564 / 15571
页数:8
相关论文